- Report
- August 2025
- 193 Pages
Global
From €3134EUR$3,545USD£2,706GBP
€3483EUR$3,939USD£3,007GBP
- Report
- August 2025
- 194 Pages
Global
From €3483EUR$3,939USD£3,007GBP
- Report
- August 2025
- 198 Pages
Global
From €3483EUR$3,939USD£3,007GBP
- Report
- August 2025
- 190 Pages
Global
From €3483EUR$3,939USD£3,007GBP
- Report
- March 2025
- 200 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- July 2024
- 150 Pages
Global
From €3316EUR$3,750USD£2,862GBP
- Report
- January 2024
- 109 Pages
United States
€3095EUR$3,500USD£2,672GBP
Beclomethasone is a corticosteroid drug used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is used to reduce inflammation in the airways, allowing for easier breathing. Beclomethasone is available in both inhaler and nebulizer forms, and is often prescribed in combination with other drugs. It is generally considered to be a safe and effective treatment for respiratory diseases.
Beclomethasone is a widely used drug in the respiratory market, and is available from many pharmaceutical companies. Some of the major players in the market include GlaxoSmithKline, Merck, Sanofi, and Teva Pharmaceuticals. Other companies such as Mylan, Sun Pharmaceuticals, and Zydus Cadila also produce beclomethasone products. Show Less Read more